CRYSTAL JEANSONNE: Open Payments
NPI 1124489372 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 20 payments from 7 companies in 2025. Trend: 2023 $748 · 2024 $909 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| ABIOMED | 2 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $47 |
| AtriCure, Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VERQUVO, LEQVIO, LifeVest, SYNERGY ABLATION SYSTEM, PIFELTRO, FUROSCIX, CAPVAXIVE, Wegovy.
Industry payments across LA — which companies pay providers there.
